For years, the idea of activating glucagon receptors for weight loss seemed counterintuitive since glucagon raises blood sugar
Notably, the observed variability in efficacy between agents, particularly in the early phases of treatment, emphasizes the importance of individualized therapeutic strategies, tailored to specific clinical goals, baseline metabolic profiles, and patient preferences
May be covered under the medical benefit with prior authorization for HMO plans
Patients should be advised that initial shedding may occur in the first few weeks, and visible improvement typically takes 36 months of consistent use
The requirements may include: BMI greater than 27 with a co-morbidity or a BMI greater than 30 without Mandate that patient participate in a weight loss management program Ultimately, plans that cover GLP-1s for weight loss want their members to know that the company supports them
ICEs defined in the GEMINI-1 protocol are premature discontinuation of treatment and use of drugs or therapies with a substantial effect on body weight before reaching the primary endpoint
